Puma Biotechnology (PBYI) Consolidated Net Income (2010 - 2026)
Puma Biotechnology's Consolidated Net Income came in at $8.25 million for Q2 2026, up 33.7% from $6.17 million a year earlier.
Powered by 
Analysis
Puma Biotechnology (PBYI) Consolidated Net Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Puma Biotechnology reported Consolidated Net Income of $31.17 million, down 25.8% year-over-year; for FY2025, it was $35.78 million, up 48.5% from FY2024.
- Going back by year, Consolidated Net Income was $24.1 million in FY2024 (+11.6%), $21.59 million in FY2023, $2,000 in FY2022 and -$29.13 million in FY2021.
- The five-year range for quarterly Consolidated Net Income is -$44.67 million (Q3 2021) to $20.32 million (Q3 2024).
- Year-over-year, Consolidated Net Income increased in three of the last five quarters, with growth averaging 53.9%.
- Business Quant data shows PBYI's Consolidated Net Income at -$3.43 million (Q1 2026), $17.11 million (Q4 2025) and $9.24 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Puma Biotechnology | 485.99 Mn | 98.62 Mn | 44.03 Mn | 8.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.25 Mn |
| Mar 31, 2026 | -3.43 Mn |
| Dec 31, 2025 | 17.11 Mn |
| Sep 30, 2025 | 9.24 Mn |
| Jun 30, 2025 | 6.17 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 12.24 Mn |
| Sep 30, 2024 | 20.32 Mn |
| Jun 30, 2024 | -4.53 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | -5.61 Mn |
| Sep 30, 2022 | -360,000.00 |
| Jun 30, 2022 | 9.37 Mn |
| Mar 31, 2022 | -3.40 Mn |
| Dec 31, 2021 | 4.22 Mn |
| Sep 30, 2021 | -44.67 Mn |
API Access
Puma Biotechnology Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();